Trends in Pharmacological Sciences
Therapeutic vaccination for spinal cord injury: helping the body to cure itself
Section snippets
Adaptive immunity, in the form of an immune response to self, as a defense mechanism
We have shown that passive transfer of autoimmune T cells into rats with either ONI or SCI results in improved recovery both morphologically and functionally 16, 18. Initially, this unexpected finding was received with skepticism because of the prevailing dogma that: (1) any immune activity in the CNS is detrimental; (2) autoimmunity is destructive; (3) passive transfer of autoimmune T cells is known to cause EAE; and (4) SCI in rats evokes an autoimmune response that in EAE-susceptible rats,
The outcome of well-controlled inflammation is beneficial
Our group has shown recently that after CNS insult, the naturally occurring CD4+CD25+ regulatory T (TRg) cells suppress the ability to manifest a protective T-cell-mediated response 35, 36. This cell population 37, 38 is the same as that discovered years ago and identified as thymus-derived suppressor T cells responsible for maintaining tolerance to self in the periphery [39]. Using transgenic mice that overexpress the T-cell receptor to myelin basic protein (tMBP/Rg+) [30], our group showed
Therapeutic boosting versus therapeutic suppression of inflammation after SCI
Recommendations from the National Acute Spinal Cord Injury Studies include the administration of high doses of intravenous MP as the standard method of treatment for patients with SCI [48]. However, the effect of MP treatment on the outcome of CNS injury is still a matter of controversy 49, 50, 51, 52.
If we assume that MP has some beneficial effect at an early stage after the insult, we need to consider how anti-inflammatory and pro-inflammatory treatments can be combined for the patient's
Concluding remarks
The findings outlined above indicate that induction of a well-controlled T-cell-based immune response against self-antigens residing in the lesion site that stimulates protective immunity without risk of triggering an autoimmune disease might be adopted as the basis for a potential therapeutic strategy for the treatment of SCI. Because both degeneration and repair of the damaged spinal cord are highly complex processes that comprise multiple operations, it is unlikely that a single intervention
References (69)
- et al.
Spinal-cord injury
Lancet
(2002) Cellular morphology of chronic spinal cord injury in the cat: analysis of myelinated axons by line-sampling
Neuroscience
(1983)Acute inflammatory response in spinal cord following impact injury
Exp. Neurol.
(1998)Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury
Exp. Neurol.
(1999)Macrophages can modify the nonpermissive nature of the adult mammalian central nervous system
Neuron
(1990)Autoimmune T cells as potential neuroprotective therapy for spinal cord injury
Lancet
(2000)Spinal cord injury in the rat: treatment with bacterial lipopolysaccharide and indomethacin enhances cellular repair and locomotor function
Exp. Neurol.
(1994)Experimental analysis of progressive necrosis after spinal cord trauma in the rat: etiological role of the inflammatory response
Exp. Neurol.
(1997)Myelin specific Th1 cells are necessary for post-traumatic protective autoimmunity
J. Neuroimmunol.
(2002)T-cell-based immunity counteracts the potential toxicity of glutamate in the central nervous system
J. Neuroimmunol.
(2001)
Autoimmunity on alert: naturally occurring regulatory CD4+CD25+ T cells as part of the evolutionary compromise between a ‘need’ and a ‘risk’
Trends Immunol.
The third function of the thymus
Immunol. Today
High-dose methylprednisolone may do more harm for spinal cord injury
Med. Hypotheses
Dual action of glatiramer acetate (Cop-1) in the treatment of CNS autoimmune and neurodegenerative disorders
Trends Mol. Med.
A therapeutic vaccine approach to stimulate axon regeneration in the adult mammalian spinal cord
Neuron
Spinal axon regeneration induced by elevation of cyclic AMP
Neuron
Protective autoimmunity: regulation and prospects for vaccination after brain and spinal cord injuries
Trends Mol. Med.
Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity
J. Autoimmun.
Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide
Prog. Neurobiol.
Ability of rat microglia to uptake extracellular glutamate
Neurosci. Lett.
Cytokine mRNA profiles in contused spinal cord and axotomized facial nucleus suggest a beneficial role for inflammation and gliosis
Exp. Neurol.
Functional redundancy of ventral spinal locomotor pathways
J. Neurosci.
Cross talk between the immune system and the nervous system in response to injury: implications for regeneration
FASEB J.
Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord
Eur. J. Neurosci.
Vascular events after spinal cord injury: contribution to secondary pathogenesis
Phys. Ther.
Chemokine antagonist infusion promotes axonal sparing after spinal cord contusion injury in rat
J. Neurosci. Res.
Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma
J. Neurosci.
The effects of methylprednisolone and the ganglioside GM1 on acute spinal cord injury in rats
J. Neurosurg.
Neuronal survival after CNS insult is determined by a genetically encoded autoimmune response
J. Neurosci.
Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats
Nat. Med.
MIP-1α, MCP-1, GM-CSF, and TNF-α control the immune cell response that mediates rapid phagocytosis of myelin from the adult mouse spinal cord
J. Neurosci.
Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy
Nat. Med.
Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion
J. Neurosci.
Regeneration of axons in the vertebrae central nervous system
Physiol. Rev.
Cited by (80)
The lncRNA Ftx/miR-382-5p/Nrg1 axis improves the inflammation response of microglia and spinal cord injury repair
2021, Neurochemistry InternationalCoVaccine HT™ adjuvant is superior to Freund's adjuvants in eliciting antibodies against the endogenous alarmin HMGB1
2016, Journal of Immunological MethodsCitation Excerpt :In summary our results show that mice pre-treated with CV elicited Abs exhibit a lower level of morbidity and mortality than mice administrated FA elicited Abs. Passive polyclonal Ab therapies have become an effective approach in treating diseases with high morbidity and mortality (Tolstrup et al., 2006) especially in complex disease scenarios where therapies are needed to target poorly immunogenic self-antigens (Harrison, 2008; Keijzer et al., 2013; Kazatchkine & Kaveri, 2001; Brody & Holtzman, 2008; Schwartz & Kipnis, 2001; Fisher et al., 2001; Hauben et al., 2001; Hauben & Schwartz, 2003). While immunisation strategies that induce potent Ab responses are continuously undergoing development, they still require the use of an adjuvant to make large stocks of high affinity Abs (Fraser et al., 2007; Hermeling et al., 2004).
"Tissue-repairing" blood-derived macrophages are essential for healing of the injured spinal cord: From skin-activated macrophages to infiltrating blood-derived cells?
2010, Brain, Behavior, and ImmunityCitation Excerpt :In addition, peripheral depletion using antibodies directed at CCR2 expressed on the monocytes resulted in a similar impairment in recovery. Similarly, a correlation was found between increased recruitment of monocytes (lasting from day 3 to approximately 1 week after injury), and improved recovery induced by active T-cell based vaccination with peptides representing altered myelin antigens (Hauben et al., 2001; Hauben and Schwartz, 2003; Ziv et al., 2006). Moreover, the improved recovery that was associated with the enhanced recruitment of monocyte-derived macrophages was abrogated when the macrophages were depleted either by conditional ablation or using lineage-specific antibodies (Shechter et al., 2009).
Immunization with neural-derived antigens inhibits lipid peroxidation after spinal cord injury
2010, Neuroscience LettersProtective autoimmunity in the nervous system
2009, Pharmacology and Therapeutics